MYOCARDIAL INFARCT

Clinical trials for MYOCARDIAL INFARCT explained in plain language.

Never miss a new study

Get alerted when new MYOCARDIAL INFARCT trials appear

Sign up with your email to follow new studies for MYOCARDIAL INFARCT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New drug aims to cool down heart attack risk

Disease control Recruiting now

This study is testing if a new drug called orticumab can reduce harmful inflammation in the heart arteries of people who have had a heart attack. Researchers will compare the drug's effects against a placebo in 240 participants over 6 months, using special heart scans to measure …

Matched conditions: MYOCARDIAL INFARCT

Phase: PHASE2 • Sponsor: Abcentra • Aim: Disease control

Last updated Mar 23, 2026 15:18 UTC

MYOCARDIAL INFARCT

Get alerted when new MYOCARDIAL INFARCT trials appear

New drug aims to cool down heart attack risk